Onglyza approved in EU in combination with other diabetes drugs

10/5/2009 | Google

European regulators approved AstraZeneca and Bristol-Myers Squibb's diabetes medicine Onglyza as a combination treatment with metformin or two other standard drugs for Type 2 diabetes. The companies plan to roll out Onglyza in the EU by the end of the year.

View Full Article in:

Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY